𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Papillary serous carcinoma of ovarian type of the testis with borderline differentiation

✍ Scribed by R Guarch; A Rivas; A Puras; C Pesce

Book ID
108779814
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
183 KB
Volume
46
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular determinants of tumor differen
Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
✍ Amir A. Jazaeri; Karen Lu; Rosemarie Schmandt; Charles P. Harris; Pulivarthi H. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 225 KB

## Abstract In epithelial ovarian cancer, tumor grade is an independent prognosticator whose molecular determinants remain unknown. We investigated patterns of gene expression in well‐ and poorly differentiated serous papillary ovarian and peritoneal carcinomas with cDNA microarrays. A 6500‐feature

Peritoneal papillary serous carcinoma: S
Peritoneal papillary serous carcinoma: Study of 15 cases and comparison with stage iii–iv ovarian papillary serous carcinoma
✍ Piura, Benjamin; Meirovitz, Mihai; Bartfeld, Mary; Yanai-Inbar, Ilana; Cohen, Yo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

Background and Objectives: Peritoneal papillary serous carcinoma (PPSC) is histologically and clinically similar to stage III-IV ovarian papillary serous carcinoma (OPSC). The purpose of this study was to investigate the clinical findings, treatment, and outcome of PPSC patients compared with stage

Treatment of micropapillary serous ovari
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)
✍ Jeffrey D. Seidman; Robert J. Kurman πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 1 views

Ovarian serous borderline tumors recently were categorized into benign and malignant types. A subset of these tumors, termed β€œmicropapillary serous carcinoma (MPSC),” is reported to behave in a manner similar to low‐grade carcinoma. In this issue of __Cancer__, Bristow et al. report their experience